Tag Archives: Approved

Lynparza (olaparib) Approved in the US as a First-Line Maintenance Treatment of Germline BRCA-Mutated Metastatic Pancreatic Cancer

Print this page 30 December 2019 — AstraZeneca and Merck & Co., Inc., Kenilworth, N.J., US (Merck: known as MSD outside the US and Canada) today announced that Lynparza® (olaparib) has been approved in the US for the maintenance treatment of adult patients with deleterious or suspected deleterious germline BRCA-mutated (gBRCAm) metastatic pancreatic adenocarcinoma whose… Read More »

Lasmiditan: New first-in-class drug treatment approved for migraine

Migraine is a huge medical problem, accounting for half of the disability produced by all neurologic diseases worldwide. The medication sumatriptan (Imitrex) is well known for the treatment of a migraine attack. Sumatriptan is part of a group of medications known as the triptans. Triptan medications have been in use for over 20 years and… Read More »

Abbott Proclaim XR 10-Year Spinal Cord Stimulator FDA Approved for Chronic Pain

September 26th, 2019 Medgadget Editors Neurology, Neurosurgery, Pain Management Abbott won approval for and is releasing a new spinal cord stimulator that can treat chronic pain for up to ten years without requiring a recharge. The Proclaim XR delivers a low dose version of Abbott’s unique BurstDR waveform, which supposedly delivers a signal similar to… Read More »